Our Ambition
Our Ambition
Build a global best-in-class beauty and wellness multi-brand platform by creating, acquiring, accelerating, and scaling the next generation of high-growth, purpose-driven brands.
Build a global best-in-class beauty and wellness multi-brand platform by creating, acquiring, accelerating, and scaling the next generation of high-growth, purpose-driven brands.
Latest News
View All
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
Waldencast Reports Q1 2025 Financial Results
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
NASDAQ: 0 (0.00%)
WALD $1.87